RxDoctor Payments DataLook up a doctor →

Jamil Aboulhosn, MD

Cardiovascular Disease · Los Angeles, CANPI 1356382717

Payments from drug & device makers

$683,319in general payments, 2019–2025

Across 555 payments — averaging $1231.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$454K
  • Medtronic$138K
  • Abbott$54K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16K
  • Janssen Research & Development, LLC$8K
  • Siemens Medical Solutions USA, Inc.$7K
  • plus $7K from 11 others

What the payments were for

  • Consulting fees$216,40351%
  • Speaking & faculty fees$155,26737%
  • Travel & lodging$37,5159%
  • Food & beverage$13,3283%
  • Education$960%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$683,319 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California

Medicare billing

Part B allowed, 2024
$98,129
Medicare patients
184
Services billed
919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban74$91,864
FarxigaDapagliflozin Propanediol58$65,736
Tadalafil17$18,639
Repatha SureclickEvolocumab17$15,046
Praluent PenAlirocumab22$10,649
Potassium Chloride18$3,341
Metoprolol Succinate70$1,394
Spironolactone54$714
Atorvastatin Calcium59$589
Losartan Potassium54$490
Furosemide81$489
Digoxin20$428
Metoprolol Tartrate30$287
Carvedilol20$282
Atenolol17$256

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →